Cipla, Boehringer Ingelheim join hands to co-market 3 oral anti-diabetic drugs in India - Android

Get it on Google Play

Cipla, Boehringer Ingelheim join hands to co-market 3 oral anti-diabetic drugs in India - Android

New Delhi, Jun 29: Pharma major Cipla and drug firm Boehringer Ingelheim India on Monday announced partnership to co-market three new oral anti-diabetic drugs in the country. The companies have entered into a partnership for co-marketing three new

29/06/2020 04:40 PM